Genetic variants associated with glycemic and weight loss response to vildagliptin as add-on therapy to metformin in Egyptian obese type 2 diabetic patients: potential consequences on cardiac risk factors.

Additionally, glycemic responders showed a higher reduction in Hcy level [−24.2 (−31.6 to 11.13)] compared to the non-responders’ group [−14.3 (−50.3 to 8.74)] however, this difference did not reach statistical significance between the two groups.

also in 111,027 other papers